App1: An antiphagocytic protein that binds to complement receptors 3 and 2

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 84-91

  Stano, Paola ^a   Williams, Virginia ^a   Villani, Maristella ^a   Cymbalyuk, Eugene S ^a   Qureshi, Asfia ^a   Huang, Yuxiang ^a   Morace, Giulia ^c   Luberto, Chiara ^a   Tomlinson, Stephen ^a   Del Poeta, Maurizio ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPHAGOCYTIC PROTEIN 1; CD11B ANTIGEN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 2; COMPLEMENT RECEPTOR 3; EPITOPE; FC RECEPTOR; FUNGAL PROTEIN; UNCLASSIFIED DRUG; APP1 PROTEIN, CRYPTOCOCCUS NEOFORMANS; CARRIER PROTEIN; COMPLEMENT COMPONENT C3D RECEPTOR; FUNGUS ANTIBODY; MONOCLONAL ANTIBODY;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ERYTHROCYTE; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHO CELL; CRICETULUS; GENETICS; HAMSTER; HELA CELL; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOGENICITY;

ANIMALS; ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; CARRIER PROTEINS; CHO CELLS; CRICETINAE; CRICETULUS; CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; HELA CELLS; HUMANS; MACROPHAGE-1 ANTIGEN; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS; PROTEIN BINDING; RECEPTORS, COMPLEMENT 3D;

EID: 59849118749     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.84     Document Type: Article

References (42)

1. Luberto, C., B. Martinez-Marino, D. Taraskiewicz, B. Bolanos, P. Chitano, D. L. Toffaletti, G. M. Cox, J. R. Perfect, Y. A. Hannun, E. Balish, and M. Del Poeta. 2003. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J. Clin. Invest. 112: 1080-1094.
2. Mare, L., R. Iatta, M. T. Montagna, C. Luberto, and M. Del Poeta. 2005. APP1 transcription is regulated by IPC1-DAG pathway and is controlled by ATF2 transcription factor in Cryptococcus neoformans. J. Biol. Chem. 280: 36055-36064.
3. Tommasino, N., M. Villani, A. Qureshi, J. Henry, C. Luberto, and M. Del Poeta. 2008. Atf2 transcription factor binds to the APP1 promoter in Cryptococcus neoformans: stimulatory effect of diacylglycerol. Eukaryot. Cell 7: 294-301.
4. Walport, M. J. 2001. Complement: second of two parts. N. Engl. J. Med. 344: 1140-1144.
5. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
6. Kozel, T. R. 1996. Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9: 34-46.
7. Levitz, S. M. 2002. Receptor-mediated recognition of Cryptococcus neoformans. Jpn. J. Med. Mycol. 43: 133-136.
8. Carroll, M. C. 2000. The role of complement in B cell activation and tolerance. Adv. Immunol. 74: 61-88.
9. Carroll, M. C. 2004. The complement system in B cell regulation. Mol. Immunol. 41: 141-146.
10. Hatzfeld, A., E. Fischer, J. P. Levesque, R. Perrin, J. Hatzfeld, and M. D. Kazatchkine. 1988. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line. J. Immunol. 140: 170-175.
11. Forsyth, C. B., E. F. Plow, and L. Zhang. 1998. Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit. J. Immunol. 161: 6198-6205.
12. Newman, S. L., S. Chaturvedi, and B. S. Klein. 1995. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J. Immunol. 154: 753-761.
13. Cross, C. E., H. L. Collins, and G. J. Bancroft. 1997. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans. Immunology 91: 289-296.
14. Dong, Z. M., and J. W. Murphy. 1997. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect. Immun. 65: 557-563.
15. Taborda, C. P., and A. Casadevall. 2002. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16: 791-802.
16. Levitz, S. M., and A. Tabuni. 1991. Binding of Cryptococcus neoformans by human cultured macrophages: requirements for multiple complement receptors and actin. J. Clin. Invest. 87: 528-535.
17. Fang, Y., C. Xu, Y. X. Fu, V. M. Holers, and H. Molina. 1998. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160: 5273-5279.
18. Szakonyi, G., J. M. Guthridge, D. Li, K. Young, V. M. Holers, and X. S. Chen. 2001. Structure of complement receptor 2 in complex with its C3d ligand. Science 292: 1725-1728.
19. Clemenza, L., and D. E. Isenman. 2000. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21). J. Immunol. 165: 3839-3848.
20. Gilbert, H. E., J. T. Eaton, J. P. Hannan, V. M. Holers, and S. J. Perkins. 2005. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an x-ray scattering and sedimentation modelling study. J. Mol. Biol. 346: 859-873.
21. Hannan, J. P., K. A. Young, J. M. Guthridge, R. Asokan, G. Szakonyi, X. S. Chen, and V. M. Holers. 2005. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d. J. Mol. Biol. 346: 845-858.
22. Feldmesser, M., J. Rivera, Y. Kress, T. R. Kozel, and A. Casadevall. 2000. Antibody interactions with the capsule of Cryptococcus neoformans. Infect. Immun. 68: 3642-3650.
23. Casadevall, A., A. Cassone, F. Bistoni, J. E. Cutler, W. Magliani, J. W. Murphy, L. Polonelli, and L. Romani. 1998. Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? Med. Mycol. 36: 95-105.
24. Vecchiarelli, A. 2000. Immunoregulation by capsular components of Cryptococcus neoformans. Med. Mycol. 38: 407-417.
25. Murphy, J. W. 1999. Immunological down-regulation of host defenses in fungal infections. Mycoses 42 (Suppl. 2): 37-43.
26. Rittershaus, P. C., T. B. Kechichian, J. Allegood, A. H. J. Merrill, M. Hennig, C. Luberto, and M. Del Poeta. 2006. Glucosylceramide is an essential regulator of pathogenicity of Cryptococcus neoformans. J. Clin. Invest. 116: 1651-1659.
27. Rodrigues, M. L., L. Nimrichter, D. L. Oliveira, S. Frases, K. Miranda, O. Zaragoza, M. Alvarez, A. Nakouzi, M. Feldmesser, and A. Casadevall. 2007. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot. Cell 6: 48-59.
28. Kinoshita, T., J. Takeda, K. Hong, H. Kozono, H. Sakai, and K. Inoue. 1988. Monoclonal antibodies to mouse complement receptor type 1 (CR1): their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J. Immunol. 140: 3066-3072.
29. Kaya, Z., M. Afanasyeva, Y. Wang, K. M. Dohmen, J. Schlichting, T. Tretter, D. Fairweather, V. M. Holers, and N. R. Rose. 2001. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat. Immunol. 2: 739-745.
30. Kaya, Z., T. Tretter, J. Schlichting, F. Leuschner, M. Afanasyeva, H. A. Katus, and N. R. Rose. 2005. Complement receptors regulate lipopolysaccharide- induced T-cell stimulation. Immunology 114: 493-498.
31. Holers, V. M. 1989. Complement receptors. Year Immunol. 4: 231-240.
32. Dierich, M. P., T. F. Schulz, A. Eigentler, H. Huemer, and W. Schwable. 1988. Structural and functional relationships among receptors and regulators of the complement system. Mol. Immunol. 25: 1043-1051.
33. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93: 3357-3361.
34. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4: 251-262.
35. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13: 127-149.
36. Tedder, T. F., L. J. Zhou, and P. Engel. 1994. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15: 437-442.
37. Chretien, F., O. Lortholary, I. Kansau, S. Neuville, F. Gray, and F. Dromer. 2002. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J. Infect. Dis. 186: 522-530.
38. Romani, L., F. Bistoni, and P. Puccetti. 2003. Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr. Opin. Microbiol. 6: 338-343.
39. Romani, L., C. Montagnoli, S. Bozza, K. Perruccio, A. Spreca, P. Allavena, S. Verbeek, R. A. Calderone, F. Bistoni, and P. Puccetti. 2004. The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. Int. Immunol. 16: 149-161.
40. Yan, J., V. Vetvicka, Y. Xia, M. Hanikyrova, T. N. Mayadas, and G. D. Ross. 2000. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble β-glucan. Immunopharmacology 46: 39-54.
41. Vetvicka, V., M. Hanikyrova, J. Vetvickova, and G. D. Ross. 1999. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumor target cell MHC class I molecules. Clin. Exp. Immunol. 115: 229-235.
42. Erdei, A., J. Prechl, A. Isaak, and E. Molnar. 2003. Regulation of B-cell activation by complement receptors CD21 and CD35. Curr. Pharm. Design 9: 1849-1860.